Clinical Trial

A Study of Cetuximabβ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer

Study acronym: SUPβORT
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A study of Cetuximabβ combined with Envolimab and mFOLFOX6 in Subjects with Advanced Colorectal Cancer
Trial Details
NCT Number NCT07000305
Lead Sponsor Tao Zhang
Conditions Advanced Colorectal Cancer
Enrollment 42 participants
Start Date 2025-05-20
Primary Completion 2027-05-20 (estimated)
Study Completion 2028-05-20 (estimated)
Updated on ClinicalTrials.gov 2025-06-02